Amplatzer patent foramen ovale occluder: safety and efficacy

References

• Hart RG, Diener H-C, Coutts SB, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13(4):429–438.
   PubMed Web of Science ®Google Scholar
• Messé SR, Gronseth G, Kent DM, et al. Practice advisory: recurrent stroke with patent foramen ovale (update of practice parameter). Neurology. 2016;87(8):815.
   PubMed Web of Science ®Google Scholar
• Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160–2236.
   PubMed Web of Science ®Google Scholar
• Whitlock RP, Sun JC, Fremes SE, et al. Antithrombotic and thrombolytic therapy for valvular disease. Chest. 2012;141(2):e576S–e600S.
   PubMed Web of Science ®Google Scholar
• Arauz A, Murillo L, Márquez JM, et al. Long-term risk of recurrent stroke in young cryptogenic stroke patients with and without patent foramen ovale. Int J Stroke. 2012;7(8):631–634.
   PubMed Web of Science ®Google Scholar
• Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377(11):1022–1032.
   PubMed Web of Science ®Google Scholar
• Mas J-L, Derumeaux G, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs antiplatelets after stroke. N Engl J Med. 2017;377(11):1011–1021.
   PubMed Web of Science ®Google Scholar
• Søndergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377(11):1033–1042.
   PubMed Web of Science ®Google Scholar
• Lee PH, Song J-K, Kim JS, et al. Cryptogenic stroke and high-risk patent foramen ovale. J Am Coll Cardiol. 2018;71(20):2335–2342.
   PubMed Web of Science ®Google Scholar
• King T, Mills NL. Nonoperative closure of atrial septal defects. Surgery. 1974;75(3):383–388.
   PubMed Web of Science ®Google Scholar
• Bridges ND, Hellenbrand W, Latson L, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation. 1992;86(6):1902–1908.
   PubMed Web of Science ®Google Scholar
• Meier B. Patent foramen ovale and closure technique with the Amplatzer occluder. 2014. Available from: www.hindawi.com/journals/scientifica/2014/129196.
   Google Scholar
• Collado FMS, Poulin M, Murphy JJ, et al. Patent foramen ovale closure for stroke prevention and other disorders. J Am Heart Assoc. 2018;7(12):e007146.
   PubMed Web of Science ®Google Scholar
• Meier B. Patent foramen ovale – Amplatzer PFO occluders. In: Interventions in Structural, Valvular, and Congenital Heart Disease. Sievert H, Qureshi SA, Wilson N, Hijazi ZM (eds). CRC Press, second edition, 2015. pp 501-522.
   Google Scholar
• Wahl A, Tai T, Praz F, et al. Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the Amplatzer PFO occluder without intraprocedural echocardiography. JACC Cardiovasc Interv. 2009;2(2):116–123.
   PubMed Web of Science ®Google Scholar
• Meier B. Pacman sign during device closure of the patent foramen ovale. Catheter Cardiovasc Interv. 2003;60(2):221–223.
   PubMed Web of Science ®Google Scholar
• Wahl A, Windecker S, Meier B. Percutaneous closure of patent foramen ovale with the Amplatzer PFO occluder. In: Herrmann HC, editor. Interventional cardiology. Totowa, NJ: Humana Press; 2005. p. 143–160.
   Google Scholar
• Susuri N, Obeid S, Ulmi M, et al. Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale. EuroIntervention. 2017;13(7):858–866.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Bajaj NS, Kumbhani DJ, et al. Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism. Jacc Cardiovasc Interv. 2012;5(7):777–789.
   PubMed Web of Science ®Google Scholar
• Onorato E, Melzi G, Casilli F, et al. Patent Foramen Ovale with paradoxical embolism: mid-term results of transcatheter closure in 256 patients. J Interv Cardiol. 2003;16(1):43–50.
   PubMedGoogle Scholar
• Trabattoni D, Gaspardone A, Sgueglia GA, et al. Amplatzer versus Figulla occluder for transcatheter patent foramen ovale closure. EuroIntervention. 2017;12(17):2092–2099.
   PubMed Web of Science ®Google Scholar
• Schwerzmann M, Windecker S, Wahl A, et al. Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy. Heart. 2004;90(2):186–190.
   PubMed Web of Science ®Google Scholar
• Tsivgoulis G, Katsanos AH, Mavridis D, et al. Percutaneous patent foramen ovale closure for secondary stroke prevention: network meta-analysis. Neurology. 2018;91(1):e8–18.
   PubMed Web of Science ®Google Scholar
• Hornung M, Bertog SC, Franke J, et al. Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale. Eur Heart J. 2013;34(43):3362–3369.
   PubMed Web of Science ®Google Scholar
• Melikian N, MacCarthy PA. The spectrum of PFO closure devices. Cardiol Today. 2017;11:55–57.
   Google Scholar
• Rigatelli G, Zuin M. Transcatheters for closure of patent foramen ovales. Expert Rev Med Devices. 2018;15(4):277–281.
   PubMed Web of Science ®Google Scholar
• Majunke N, Baranowski A, Zimmermann W, et al. A suture not always the ideal solution: problems encountered in developing a suture-based PFO closure technique. Catheter Cardiovasc Interv. 2009;73(3):376–382.
   PubMed Web of Science ®Google Scholar
• Sievert H, Ruygrok P, Salkeld M, et al. Transcatheter closure of patent foramen ovale with radiofrequency: acute and intermediate term results in 144 patients. Catheter Cardiovasc Interv. 2009;73(3):368–373.
   PubMed Web of Science ®Google Scholar
• Reiffenstein I, Majunke N, Wunderlich N, et al. Percutaneous closure of patent foramen ovale with a novel FlatStentTM. Expert Rev Med Devices. 2008;5(4):419–425.
   PubMed Web of Science ®Google Scholar
• Mullen MJ, Hildick-Smith D, De Giovanni JV, et al. BioSTAR evaluation study (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts. Circulation. 2006;114(18):1962–1967.
   PubMed Web of Science ®Google Scholar
• Van Den Branden BJ, Post MC, Plokker HW, et al. Patent foramen ovale closure using a bioabsorbable closure device. JACC Cardiovasc Interv. 2010;3(9):968–973.
   PubMed Web of Science ®Google Scholar
• Happel CM, Laser KT, Sigler M, et al. Single center experience: implantation failures, early, and late complications after implantation of a partially biodegradable ASD/PFO-device (BioStar®). Catheter Cardiovasc Interv. 2015;85(6):990–997.
   PubMed Web of Science ®Google Scholar
• Mehan VK, Wahl A, Walpoth N, et al. Instant percutaneous closure of patent foramen ovale in patients with acute myocardial infarction and normal coronary arteries. Catheter Cardiovasc Interv. 2006;67(2):279–282.
   PubMed Web of Science ®Google Scholar
• Dao CN, Tobis JM. PFO and paradoxical embolism producing events other than stroke. Catheter Cardiovasc Interv. 2011;77(6):903–909.
   PubMed Web of Science ®Google Scholar
• Nozari A, Dilekoz E, Sukhotinsky I, et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol. 2010;67(2):221–229.
   PubMed Web of Science ®Google Scholar
• Kanwar SM, Noheria A, DeSimone CV, et al. Coincidental impact of transcatheter patent foramen ovale closure on migraine with and without aura – a comprehensive meta-analysis. Clin Trials Regul Sci Cardiol. 2016;15:7–13.
   PubMedGoogle Scholar
• Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention With STARFlex Technology (MIST) Trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008;117(11):1397–1404.
   PubMed Web of Science ®Google Scholar
• Mattle HP, Evers S, Hildick-Smith D, et al. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. Eur Heart J. 2016;37(26):2029–2036.
   PubMed Web of Science ®Google Scholar
• Tobis JM, Charles A, Silberstein SD, et al. Percutaneous closure of patent foramen ovale in patients with migraine. J Am Coll Cardiol. 2017;70(22):2766–2774.
   PubMed Web of Science ®Google Scholar
• Meier B. Patent foramen ovele, good reasons to close it. Dtsch Med Wochenschr. 1946–2018;143(5):354–356.
   Google Scholar
• Kheiri B, Abdalla A, Osman M, et al. Percutaneous closure of patent foramen ovale in migraine. JACC Cardiovasc Interv. 2018;11(8):816–818.
   PubMed Web of Science ®Google Scholar
• Knauth M, Ries S, Pohimann S, et al. Cohort study of multiple brain lesions in sport divers: role of a patent foramen ovale. BMJ. 1997;314(7082):701.
   PubMed Web of Science ®Google Scholar
• Schwerzmann M, Seiler C, Lipp E, et al. Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers. Ann Intern Med. 2001;134(1):21–24.
   PubMed Web of Science ®Google Scholar
• Allemann Y, Hutter D, Lipp E, et al. Patent foramen ovale and high-altitude pulmonary Edema. JAMA. 2006;296(24):2954.
   PubMed Web of Science ®Google Scholar
• Lovering AT, Elliott JE, Davis JT. Physiological impact of patent foramen ovale on pulmonary gas exchange, ventilatory acclimatization, and thermoregulation. J Appl Physiol. 2016;121(2):512–517.
   PubMed Web of Science ®Google Scholar
• Shanoudy H, Soliman A, Raggi P, et al. Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep Apnea. Chest. 1998;113(1):91–96.
   PubMed Web of Science ®Google Scholar
• Soliman A, Shanoudy H, Liu J, et al. Increased prevalence of patent foramen ovale in patients with severe chronic obstructive pulmonary disease. J Am Soc Echocardiogr. 1999;12:99–105.
   PubMed Web of Science ®Google Scholar
• Meier B. Some air for closure of the patent foramen ovale. JACC Cardiovasc Interv. 2012;5(4):420–421.
   PubMed Web of Science ®Google Scholar
• Cheng TO. Platypnea-orthodeoxia syndrome: etiology, differential diagnosis, and management. Catheter Cardiovasc Interv. 1999;47(1):64–66.
   PubMed Web of Science ®Google Scholar
• Zaker‐Shahrak R, Fuhrer J, Meier B. Transseptal puncture for catheter ablation of atrial fibrillation after device closure of patent foramen ovale. Catheter Cardiovasc Interv. 2008;71(4):551–552.
   PubMed Web of Science ®Google Scholar
• Honari G, Ellis SG, Wilkoff BL, et al. Hypersensitivity reactions associated with endovascular devices. Contact Dermatitis. 2008;59(1):7–22.
   PubMed Web of Science ®Google Scholar
• Fukahara K, Minami K, Reiss N, et al. Systemic allergic reaction to the percutaneous patent foramen ovale occluder. J Thorac Cardiovasc Surg. 2003;125(1):213–214.
   PubMed Web of Science ®Google Scholar
• Ries MW, Kampmann C, Rupprecht H-J, et al. Nickel release after implantation of the Amplatzer occluder. Am Heart J. 2003;145(4):737–741.
   PubMed Web of Science ®Google Scholar
• Verma SK, Tobis JM. Explantation of patent foramen ovale closure devices. JACC Cardiovasc Interv. 2011;4(5):579–585.
   PubMed Web of Science ®Google Scholar
• Mojadidi MK, Elgendy AY, Elgendy IY, et al. Transcatheter patent foramen ovale closure after cryptogenic stroke. JACC Cardiovasc Interv. 2017;10(21):2228–2230.
   PubMed Web of Science ®Google Scholar
• Krumsdorf U, Ostermayer S, Billinger K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol. 2004;43(2):302–309.
   PubMed Web of Science ®Google Scholar
• Amin Z, Hijazi ZM, Bass JL, et al. PFO closure complications from the AGA registry. Catheter Cardiovasc Interv. 2008;72(1):74–79.
   PubMed Web of Science ®Google Scholar
• Meier B. Optimal stroke prevention in patients with patent foramen ovale. Lancet Neurol. 2018;17(12):1027–1028.
   PubMed Web of Science ®Google Scholar
• Madhkour R, Meier B. Patent foramen ovale closure, a contemporary review. Struct Heart. 2018;2(2):114–120.
   Web of Science ®Google Scholar